Clinical trial · Observational
Sonography for COVID-19 Vaccines Related Reactive Lymphadenopathy
Sonography for COVID-19 Vaccines Related Reactive Lymphadenopathy: A Retrospective Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aimed to provide vast clinical information to facilitate breast sonographic examination for participants who underwent recent SARS-CoV-2 vaccination. Among different SARS-CoV-2 vaccines in the Asian Taiwanese population, reactive axillary lymphadenopathy was investigated through breast sonographic findings and clinical data analysis. The sample included participants with recent vaccinations by different brands approved in Taiwan.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Reactive Axillary Lymphadenopathy for SARS-CoV-2 Vaccines in the Asian Taiwanese Population | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| the AstraZeneca ChAdOx1 (AZ) vaccine, Moderna mRNA-1273 (Moderna) vaccine, and Pfizer-BioNTech BNT162b2 (BNT) vaccine. | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- control group
- description
- non SARS-COV-2 vaccinated group
- label
- vaccinated group
- description
- SARS-COV-2 vaccinated group
- interventionNames
- Biological: the AstraZeneca ChAdOx1 (AZ) vaccine, Moderna mRNA-1273 (Moderna) vaccine, and Pfizer-BioNTech BNT162b2 (BNT) vaccine.
Primary outcomes (1)
- measure
- Presentation of axillary lymphadenopathy in sonographic examination
- timeFrame
- through study completion, an average of 1 year
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * female patients receiving breast sonography Exclusion Criteria: * receive Covid 19 vaccine other than AZ, BNT, Moderna * Ongoing primary breast malignancy * History of malignancy other than primary breast malignancy
References
Publications (0)
Data not yet available